Musika wekambani, kushandiswa kwemabhiza nhasi
Stock quotes yekambani 71229 munguva chaiyo chaiye.
Musika wekambani, kushandiswa kwemabhiza nhasi

Stock quotes

Stock quotes online

Stock quotes history

Stock market capitalization

Stock Dividends

Kubatsira kubva kumakambani emakambani

Mishumo yemari

Rating share of companies. Ndekupi kwatingaisa mari?

Novus Therapeutics, Inc. mutengo wemakesi

Nhamba yekutengeserana kwemabhizimisi Novus Therapeutics, Inc. nhasi uye nhoroondo yemudzimai we Novus Therapeutics, Inc. kubva pakutanga kwekutengeserana muNVUS mashizha mukutengesa.
Wedzera kune zvakasarudzwa
Yakawedzerwa kumajairika

Novus Therapeutics, Inc. capitalization

Mazuva ano misika yemakemikari ye Novus Therapeutics, Inc. is 20 970 272 US dhora.
-732 522 $ (-3.38%)
shanduko ye capitalization kubva zuro

Novus Therapeutics, Inc. capitalization inovandudzwa kamwe pazuva. Zvichienderana nekutengeserana kwe stock quote Novus Therapeutics, Inc. pamusika wekutengesa masheya, unogona kuongorora capitalization ye Novus Therapeutics, Inc.. Novus Therapeutics, Inc. capitalization yanhasi pawebsite yedu yekureva. Novus Therapeutics, Inc. capitalization = 20 970 272 US madhora.

Novus Therapeutics, Inc. ivhu rekutengeserana

Nhasi kutengeswa kwezvikamu zve Novus Therapeutics, Inc. zvakave 85 924 US dhora.
+85 652 $ (+31 489.71%)
kuchinja kwehuwandu hwebhizimisi kubvira zuro

Novus Therapeutics, Inc. vhoriyamu yekutengesa nhasi - 85 924 US madhora. Nhasi, Novus Therapeutics, Inc. kutengesa kwakaitika pamisika yakawanda yemasheya. Novus Therapeutics, Inc. kutengeserana kwepamhepo kunoitwa pamisika yakawanda yemasheya, tinoratidza huwandu hwakazara hwe Novus Therapeutics, Inc. kutengesa pazuva. Novus Therapeutics, Inc. cap yekutengesa yaive yakakura nezuro.

Ratidza:
Kuti

Novus Therapeutics, Inc. musika wekodhi chati

Novus Therapeutics, Inc. capitalization pagirazi nemakore. -1.92% - shanduko mumusika capitalization ye Novus Therapeutics, Inc. vhiki. Novus Therapeutics, Inc. shanduko yemari yegore i 0%. Nhasi, Novus Therapeutics, Inc. capitalization yakaenzana ne 20 970 272 US madhora.

Vhiki Mwedzi 3 months Gore 3 years

Novus Therapeutics, Inc. capital capital history

Zuva Capitalization
Capitalization (mutengo capital) ndiyo kukosha kwemusika wezvikamu zvose zvekambani zvakatengeswa pamutengo wekutengesa. Market capitalization yakaenzana nemutengo wezvikamu zvinowanikwa nenhamba yezvikamu zvakakosha.
04/01/2021 20 970 272 $
31/12/2020 21 702 794 $
30/12/2020 21 575 250 $
29/12/2020 21 817 700 $
28/12/2020 20 998 998 $
24/12/2020 19 835 580 $
23/12/2020 21 380 486 $

Novus Therapeutics, Inc. vhidhiyo chati

Vhiki Mwedzi 3 months Gore 3 years

Novus Therapeutics, Inc. nhoroondo yemota data

Zuva Bhuku (24h)
Nhamba yekutengeserana yeNovus Therapeutics, Inc. zvikamu ndeyewandu hwezvinhu zvose zvekutengeserana neNVUS zvikamu zvakatengwa uye zvinotengeswa panguva yakasarudzwa.
04/01/2021 85 924 $
31/12/2020 272 $
30/12/2020 761 $
29/12/2020 12 683 $
28/12/2020 27 721 $
24/12/2020 24 068 $
23/12/2020 81 251 $

Novus Therapeutics, Inc. capitalization yakaenzana 20 970 272 US madhora pa 04/01/2021. Musika capitalization ye Novus Therapeutics, Inc. yakanzi 21 702 794 US madhora pa 31/12/2020. 30/12/2020 Novus Therapeutics, Inc. capitalization yakasvika 21 575 250 US madhora. 29/12/2020 Novus Therapeutics, Inc. capitalization yakaenzana 21 817 700 US madhora.

On 28/12/2020, Novus Therapeutics, Inc. misika yekutengesa yaive $ 20 998 998. 24/12/2020 Novus Therapeutics, Inc. capitalization yakasvika 19 835 580 US madhora. On 23/12/2020, Novus Therapeutics, Inc. misika yekutengesa yaive $ 21 380 486.

Iko mari yepamusoro yeNovus Therapeutics, Inc. nhasi ndeye 20 970 272 $. Imari yepamusi yeNovus Therapeutics, Inc. yakachinja -3.375% inofananidzwa nezuro. Nhamba yekutengeserana ye NVUS nhengo dze Novus Therapeutics, Inc. musi wekupedzisira wekutengesa yakava 85 924 $. Kutengeswa kwezvikamu zve Novus Therapeutics, Inc. zvakachinjwa kusvika +31 489.710% zvichienzaniswa nezuva rekutanga rebhizimisi.

Mari yezvikamu Novus Therapeutics, Inc.

Mari Novus Therapeutics, Inc.